Laboratory Billing Software & RCM Services Built for Revenue Growth

Laboratory billing services cover the full revenue cycle: eligibility verification and prior authorizations before the test runs, coding and claim submission, denial management, appeals, payment posting, and patient balance follow-up. With ADS, you can run this in-house on our laboratory practice management software, or hand the work to our billing team through MedicsRCM (ADSRCM). It is the same platform either way. The difference is who does the work.

It depends on whether you can consistently staff the function. Lab billing requires people who understand payer-specific edits, medical necessity documentation, and molecular and toxicology coding, and those people are hard to find and harder to keep. If turnover keeps resetting your AR, outsourcing usually costs less than rebuilding the team every 18 months. We broke down the tradeoff in Labs Are Struggling to Find and Retain Billing Staff.

Yes. ADS and ADSRCM integrate with virtually any LIS or LIMS for a two-way data flow between systems, and we support integrations with EHRs as well. If you are moving off an existing billing system, we handle the data conversion. You do not need to replace your LIS to work with us.

Usually because of a coverage gap, not a billing error. When there is no Local Coverage Determination governing a code, the payer has no framework for adjudicating it and defaults to denial. The same happens when LCD and NCD rules are not built into the billing workflow, and the errors stay hidden inside aging AR. See Billing Laboratory Tests Without LCDs and Lab Compliance Deep Dive: LCD/NCD Gaps.

Directly. The private payor data applicable labs reported to CMS this year sets Medicare Clinical Laboratory Fee Schedule rates starting January 1, 2027. Labs that under-reported or reported incomplete data will carry those rates for years. Our 2026 Mid-Year Lab Reimbursement Review covers what comes next, and the February 2026 Laboratory Business Insights issue walks through revenue defensibility in a post-PAMA reset environment.

A clawback is a payer recovering money it already paid you, sometimes years after the claim processed. Most labs are set up to chase payment and not to defend it, which is why clawbacks now threaten more revenue than denials at some organizations. Prevention starts with documentation and coding that hold up under retrospective review. More in The Growing Threat of Insurance Clawbacks.

Pathology claims split into technical and professional components, and getting the TC/PC split or the modifier wrong turns correct clinical work into a denial. Global billing, place of service, and specimen-level coding all add exposure under payer audit. We cover the 2026 rules in Pathology Lab Billing: CPT, TC/PC Splits, and Payer Audits.

Yes. We support clinical, toxicology, pathology, genetic, and molecular laboratories, including complex NGS billing, with fee schedules configurable by CPT, payer, or lab. For context on how new CMS mandates, FDA oversight, and payer edits are hitting these specialties specifically, see the 2026 Laboratory Billing & Compliance Update.

False Claims Act exposure, kickback arrangements, medically unnecessary testing, and billing patterns that outpace compliance controls — DOJ enforcement in these areas has tightened considerably. Layered on top are CMS and FDA changes already showing up as denials, delayed payments, and expanded documentation requests. Start with DOJ Enforcement of Clinical Laboratories and CMS, FDA, and Payer Changes Reshaping Laboratory Revenue Cycles.

Many potential denials never happen, because the system flags them before the claim goes out. For what still comes back, ADS clients can edit and resubmit directly in the platform, and ADSRCM clients have their denials resubmitted within 72 business hours by our team.

Subscribe to Laboratory Business Insights, our monthly newsletter from Jim O'Neill covering PAMA, payer enforcement, denial trends, and operational strategy for lab leaders. It is free, and it is written for lab directors, CFOs, and billing managers, not a general healthcare audience.